Investor Alert

New York Markets After Hours

Company Close Updates Archives | Email alerts

Jan. 20, 2021, 4:55 p.m. EST

AstraZeneca PLC ADR underperforms Wednesday when compared to competitors

Watchlist Relevance

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

or Cancel Already have a watchlist? Log In

MarketWatch Automation

The AstraZeneca PLC ADR AZN dropped 0.63% to $52.24 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index COMP rising 1.97% to 13,457.25 and the Dow Jones Industrial Average DJIA rising 0.83% to 31,188.38. The ADR's fall snapped a four-day winning streak. AstraZeneca PLC ADR closed $12.70 short of its 52-week high ($64.94), which the company achieved on July 20th.

The ADR underperformed when compared to some of its competitors Wednesday, as AbbVie Inc. ABBV rose 0.39% to $112.62, Amgen Inc. AMGN rose 1.65% to $252.36, and Gilead Sciences Inc. GILD rose 1.37% to $67.99. Trading volume (13.6 M) eclipsed its 50-day average volume of 11.0 M.

Editor's Note: This story was auto-generated by Automated Insights using data from Dow Jones and FactSet. See our market data terms of use.

This Story has 0 Comments
Be the first to comment
More News In

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.